send to a friend by email

Jerusalem Pharmaceuticals (JPH) earns a pretax income of JD 2.49 million in the third quarter of 2010

2010-10-31

Jerusalem Pharmaceuticals (JPH) disclosed its financial statements for the third quarter of 2010, and the company’s financial results as of 30/09/2010 indicated a pretax income of JD 2.49 million comparing to JD 1.17 million in the third quarter of 2009. The company’s assets reached JD 27.14 million at the end 30/09/2010 after they reached JD 24.95 million on 31/12/2009. Total liabilities reached JD 4.90 million at the end of the third quarter of 2010 comparing to JD 3.60 million as of 31/12/2009. Shareholders’ equity reached JD 22.24 million (minority interests of JD 95 thousand) on 30/09/2010 after they reached JD 21.35 million (minority interests of JD 108 thousand) at the end of 2009.